Merck's boceprevir cuts treatment times for hepatitis C
31 March 2011
John Hodgson
Please Login to read the full article.
31 March 2011
John Hodgson
Please Login to read the full article.
RELATED CONTENT
NEWS
- First Hep C protease head-to-head trial pits Medivir's TMC435 against J&J's telaprevir
- Gilead Hep-C pipeline drug hits speed bump: relapse in genotype 1 null responders
- Victrelis combo therapy anaemia: new study shows reducing ribavirin just as effective as adding EPO
- Pharmasset soars on $11B offer, but Gilead investors disturbed
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
